Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-20-000712
Filing Date
2020-03-06
Accepted
2020-03-06 15:44:18
Documents
77
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K organicell_10k-103118.htm 10-K 1469631
2 SUBSIDIARIES organicell_ex02101.htm EX-21.1 6248
3 CERTIFICATION organicell_ex03101.htm EX-31.1 8041
4 CERTIFICATION organicell_ex03102.htm EX-31.2 8138
5 CERTIFICATION organicell_ex03201.htm EX-32.1 4559
6 GRAPHIC image_001.jpg GRAPHIC 69111
  Complete submission text file 0001683168-20-000712.txt   7069779

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE bpsr-20181031.xml EX-101.INS 1092459
8 XBRL SCHEMA FILE bpsr-20181031.xsd EX-101.SCH 62139
9 XBRL CALCULATION FILE bpsr-20181031_cal.xml EX-101.CAL 70121
10 XBRL DEFINITION FILE bpsr-20181031_def.xml EX-101.DEF 322857
11 XBRL LABEL FILE bpsr-20181031_lab.xml EX-101.LAB 433373
12 XBRL PRESENTATION FILE bpsr-20181031_pre.xml EX-101.PRE 402602
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-55008 | Film No.: 20694457
SIC: 3790 Miscellaneous Transportation Equipment